Research and Markets: Global Human Growth Hormone Drugs - Strategic Business Report 2014
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l8l4fj/human_growth) has announced the addition of the "Human Growth Hormone Drugs - Global Strategic Business Report" report to their offering.
“Human Growth Hormone Drugs - Global Strategic Business Report”
This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, Nutropin, Saizen, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 30 companies including many key and niche players such as:
- Eli Lilly and Company
- Ferring Holding SA
- Genentech, Inc.
- GeneScience Pharmaceuticals Co., Ltd.
- Merck Serono SA
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
2. MARKET TRENDS & ISSUES
4. HUMAN GROWTH HORMONE: AN OVERVIEW
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
1. THE UNITED STATES
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 30 (including Divisions/Subsidiaries 33)
- The United States (12)
- Japan (1)
- Europe (10)
- Germany (3)
- The United Kingdom (2)
- Rest of Europe (5)
- Asia-Pacific (Excluding Japan) (8)
- Middle East (2)
For more information visit http://www.researchandmarkets.com/research/l8l4fj/human_growth